Euthymics Bioscience
  • Home
  • Our Programs
    • MAJOR DEPRESSIVE DISORDER AND AMITIFADINE
    • ADHD and EB-1020
  • Our Technology
  • About
    • About Euthymics
    • Management
    • Board of Directors
  • Contact
  • News

News

  • News
    • Corporate Fact Sheet
    • In The News
    • Press Releases
    • Publications
Home    >    Publications

Publications

December 8th - Efficacy and Safety of the Novel Triple Reuptake Inhibitor EB-1010 in the Treatment of Patients with Major Depressive Disorder


December 6th - Effects of the Unbalanced Triple Transporter Inhibitor EB-1010 on Monoamine Uptake Transporters in Vitro and in Vivo


Privacy Policy  |  Terms of Use Copyright ©2012 Euthymics Bioscience. All Rights Reserved.